These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 29505490

  • 1. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
    Manu P, Lapitskaya Y, Shaikh A, Nielsen J.
    Am J Ther; 2018; 25(2):e218-e223. PubMed ID: 29505490
    [Abstract] [Full Text] [Related]

  • 2. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.
    Manu P, Sarpal D, Muir O, Kane JM, Correll CU.
    Schizophr Res; 2012 Feb; 134(2-3):180-6. PubMed ID: 22113154
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?
    Nielsen J, Correll CU, Manu P, Kane JM.
    J Clin Psychiatry; 2013 Jun; 74(6):603-13; quiz 613. PubMed ID: 23842012
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.
    Cohen D, Bogers JP, van Dijk D, Bakker B, Schulte PF.
    J Clin Psychiatry; 2012 Oct; 73(10):1307-12. PubMed ID: 23140648
    [Abstract] [Full Text] [Related]

  • 14. Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series.
    Béchard L, Morasse-Bégis M, Corbeil O, Hakim JR, Malenfant E, Brodeur S, Huot-Lavoie M, Essiambre AM, Demers MF, Roy MA.
    J Clin Psychopharmacol; 2012 Oct; 42(4):391-395. PubMed ID: 35546087
    [Abstract] [Full Text] [Related]

  • 15. Update on the adverse effects of clozapine: focus on myocarditis.
    De Berardis D, Serroni N, Campanella D, Olivieri L, Ferri F, Carano A, Cavuto M, Martinotti G, Cicconetti A, Piersanti M, Saverio Moschetta F, Di Giannantonio M.
    Curr Drug Saf; 2012 Feb; 7(1):55-62. PubMed ID: 22663959
    [Abstract] [Full Text] [Related]

  • 16. Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review.
    Verdoux H, Quiles C, de Leon J.
    Schizophr Res; 2019 Sep; 211():1-9. PubMed ID: 31378552
    [Abstract] [Full Text] [Related]

  • 17. Protocol for Clozapine Rechallenge in a Case of Clozapine-Induced Myocarditis.
    Shivakumar G, Thomas N, Sollychin M, Takács A, Kolamunna S, Melgar P, Connally F, Neil C, Bousman C, Jayaram M, Pantelis C.
    Can J Psychiatry; 2020 Jul; 65(7):448-453. PubMed ID: 31818135
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A review of clozapine safety.
    Fitzsimons J, Berk M, Lambert T, Bourin M, Dodd S.
    Expert Opin Drug Saf; 2005 Jul; 4(4):731-44. PubMed ID: 16011451
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.